XL092, a multi-targeted inhibitor of MET, VEGFR2, AXL and MER with an optimized pharmacokinetic profile

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2020-10, Vol.138, p.S16-S16
Main Authors: Hsu, J., Chong, C., Goon, L., Balayan, J., Wu, S., Johnson, E., Lorenzana, G., Bannen, L., Nguyen, L., Scheffold, C., Lamb, P., Xu, W., Yu, P.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(20)31107-2